Germany industry debates medtech aids changes:
This article was originally published in Clinica
Representatives from Germany's IKK Guilds' health sickness fund (the one delegated as "rapporteur" on this issue of fixed reimbursement prices for medical technical aids - see Clinica No 1138, p 6) will be among the speakers at a BVMed/MedInform-organised forum on the theme of fixed prices, in Mainz on April 7. The session will deal with prescribing, how hospitals view and deal with the fixed prices, how are the prices calculated, and what will be the effect on patient care and medical technology companies. For details, a programme and for online or other registration information, contact BVMed in Berlin, on tel: +49 (0)30 246 25520; email: firstname.lastname@example.org
You may also be interested in...
Executive appointments at MyoKardia, Scancell Holdings and Sutro Biopharma
The merger between Mylan and Pfizer’s Upjohn unit finally concluded on 16 November 2020, giving Viatris the go ahead for business. The newly-established company has announced receiving tentative approval for its 10mg pediatric dolutegravir tablets from the FDA under the PEPFAR program.
Johnson & Johnson believes personalization via digital holds the key to smoking cessation success as it launches in the UK its app-supported Nicorette QuickMist SmartTrack product.